Effects of β-Endorphin on Endothelial/Monocytic Endothelin-1 and Nitric Oxide Release Mediated by μ1-Opioid Receptors: A Potential Link between Stress and Endothelial Dysfunction?

REFERENCES

• Arendt R. M., Wilbert-Lampen U., Heucke L., Schmoeckel M., Suhler K., Richter W. O. Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events. Research in Experimental Medicine (Berlin), 1993; 193: 225–230
   PubMedGoogle Scholar
• Bouis D., Hospers G. A., Meijer C., Molema G., Mulder N. H. Endothelium in vitro: A review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis, 2001; 4: 91–102
   PubMedGoogle Scholar
• Bradbury A. F., Smyth D. G., Snell C. R. Peptides, Chemistry, Structure and Biology. Ann Arbor Science Publisher, Ann Arbor, MI 1975
   Google Scholar
• Browatzki M., Pfeiffer C. A., Schmidt J., Kranzhofer R. Endothelin-1 induces CD40 but not IL-6 in human monocytes via the proinflammatory transcription factor NF-kappaB. European Journal of Medical Research, 2005; 10: 197–201
   PubMedGoogle Scholar
• Cabot P. J., Carter L., Gaiddon C., Zhang Q., Schafer M., Loeffler J. P., Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. Journal of Clinical Investigation, 1997; 100: 142–148
   PubMed Web of Science ®Google Scholar
• Castellani S., Ungar A., Cantini C., La Cava G., Di Serio C., Vallotti B., Altobelli A., Masotti G. Impaired renal adaptation to stress in the elderly with isolated systolic hypertension. Hypertension, 1999; 34: 1106–1111
   PubMedGoogle Scholar
• Charmandari E., Tsigos C., Chrousos G. Endocrinology of the stress response. Annual Reviews in Phyiology, 2005; 67: 259–284
   PubMed Web of Science ®Google Scholar
• Drexler H., Hornig B. Endothelial dysfunction in human disease. Journal of Molecular and Cellular Cardiology, 1999; 31: 51–60
   PubMed Web of Science ®Google Scholar
• Faletti A. G., Mastronardi C. A., Lomniczi A., Seilicovich A., Gimeno M., McCann S. M., Rettori V. beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release. Proceedings of the National Academy of Sciences of the United States of America, 1999; 96: 1722–1726
   PubMedGoogle Scholar
• Finsnes F., Lyberg T., Christensen G., Skjonsberg O. H. Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation. American Journal of Physiology Lung and Cellular and Molecular Physiology, 2001; 280: L659–L665
   PubMed Web of Science ®Google Scholar
• Fontana F., Bernardi P., Lanfranchi G., Conti E., Spampinato S., Di Toro R., Bonafe F., Coccheri S. Endothelin-1 response to mental stress in early ischemic lesions of the extremities due to systemic sclerosis. Peptides, 2005; 26: 2487–2490
   PubMed Web of Science ®Google Scholar
• Fontana F., Bernardi P., Merlo Pich E., Tartuferi L., Boschi S., de Iasio R., Spampinato S. Opioid peptides in response to mental stress in asymptomatic dilated cardiomyopathy. Peptides, 1998; 19: 1147–1153
   PubMedGoogle Scholar
• Habib K. E., Gold P. W., Chrousos G. P. Neuroendocrinology of stress. Endocrinology and Metabolism Clinics of North America 2001; 30: 695–728; vii–viii
   PubMed Web of Science ®Google Scholar
• Khodorova A., Navarro B., Jouaville L. S., Murphy J. E., Rice F. L., Mazurkiewicz J. E., Long-Woodward D., Stoffel M., Strichartz G. R., Yukhananov R., Davar G. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nature Medicine, 2003; 9: 1055–1061
   PubMed Web of Science ®Google Scholar
• Lam H. C., Kuo S. M., Chuang M. J., Keng H. M., Lin P. R., Liu G. S., Hsu C. M., Howng S. L., Tai M. H. Blockade of endothelin-1 release contributes to the anti-angiogenic effect by pro-opiomelanocortin overexpression in endothelial cells. Experimental Biology and Medicine (Maywood), 2006; 231: 782–788
   PubMedGoogle Scholar
• Lam H. C., Takahashi K., Ghatei M. A., Warrens A. N., Rees A. J., Bloom S. R. Immunoreactive endothelin in human plasma, urine, milk, and saliva. Journal of Cardiovascular Pharmacology, 1991; 17: S390–S393, Suppl 7
   PubMed Web of Science ®Google Scholar
• Lerman A., Holmes D. R., Jr., Bell M. R., Garratt K. N., Nishimura R. A., Burnett J. C., Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation, 1995; 92: 2426–2431
   PubMed Web of Science ®Google Scholar
• Luscher T. F., Noll G. The pathogenesis of cardiovascular disease: Role of the endothelium as a target and mediator. Atherosclerosis, 1995; 118: S81–S90, Suppl
   PubMedGoogle Scholar
• Menzebach A., Hirsch J., Hempelmann G., Welters I. D. Effects of endogenous and synthetic opioid peptides on neutrophil function in vitro. British Journal of Anaesthesis, 2003; 91: 546–550
   PubMedGoogle Scholar
• Mizoguchi H., Wu H. E., Narita M., Hall F. S., Sora I., Uhl G. R., Nagase H., Tseng L. F. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse. Neuroscience, 2002; 115: 715–721
   PubMed Web of Science ®Google Scholar
• Pike J. L., Smith T. L., Hauger R. L., Nicassio P. M., Patterson T. L., McClintick J., Costlow C., Irwin M. R. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosomatic Medicine, 1997; 59: 447–457
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis—An inflammatory disease. New England Journal of Medicine 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Rozanski A., Blumenthal J. A., Davidson K. W., Saab P. G., Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: The emerging field of behavioral cardiology. Journal of the American College of Cardiology, 2005; 45: 637–651
   PubMed Web of Science ®Google Scholar
• Rozanski A., Blumenthal J. A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 1999; 99: 2192–2217
   PubMed Web of Science ®Google Scholar
• Ruoslahti E., Rajotte D. An address system in the vasculature of normal tissues and tumors. Annual Reviews in Immunology, 2000; 18: 813–827
   PubMed Web of Science ®Google Scholar
• Seidel M., Billert H., Kurpisz M. Regulation of eNOS expression in HCAEC cell line treated with opioids and proinflammatory cytokines. Kardiologica Polska, 2006; 64: 153–158, discussion 159–160
   PubMedGoogle Scholar
• Wang X., Xu H., Rothman R. B. Regulation of the rat brain endothelin system by endogenous beta-endorphin. Peptides, 2006; 27: 769–774
   PubMedGoogle Scholar
• Wilbert-Lampen U., Straube F., Trapp A., Deutschmann A., Plasse A., Steinbeck G. Effects of corticotropin-releasing hormone (CRH) on monocyte function, mediated by CRH-receptor subtype R1 and R2: A potential link between mood disorders and endothelial dysfunction?. Journal of Cardiovascular Pharmacology, 2006a; 47: 110–116
   PubMed Web of Science ®Google Scholar
• Wilbert-Lampen U., Trapp A., Modrzik M., Fiedler B., Straube F., Plasse A. Effects of corticotropin-releasing hormone (CRH) on endothelin-1 and NO release, mediated by CRH receptor subtype R2: A potential link between stress and endothelial dysfunction?. Journal of Psychosomatic Research, 2006b; 61: 453–460
   PubMed Web of Science ®Google Scholar
• Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1988; 332: 411–415
   PubMed Web of Science ®Google Scholar
• Yang L. L., Gros R., Kabir M. G., Sadi A., Gotlieb A. I., Husain M., Stewart D. J. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation, 2004; 109: 255–261
   PubMed Web of Science ®Google Scholar
• Yasuda M., Kohno M., Tahara A., Itagane H., Toda I., Akioka K., Teragaki M., Oku H., Takeuchi K., Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. American Heart Journal, 1990; 119: 801–806
   PubMed Web of Science ®Google Scholar